Literature DB >> 34950985

Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.

Shohei Nakamura1, Tomomi Fukai1, Takatoshi Sakamoto2.   

Abstract

In recent years, orally disintegrating (OD) tablets have been continuously improved to increase efficacy. Herein, we focused on the benefits of cellulose nanofiber (CNF), a highly functional material, in OD tablet manufacturing. We studied its effects on the physical properties of tablets during manufacture. The analyzed tablet formulations included different content CNF (0-50%; 6 preparations), lactose hydrate, acetaminophen, and magnesium stearate (Mg-St). We measured the angles of repose and evaluated the flowability of the powder. Tablets were prepared on a tabletop and rotary tableting presses, whereafter their weight, drug content, hardness, friability, and disintegration time were evaluated. Although CNF addition slightly reduced powder flowability, continuous tableting was feasible via direct powder compression. Tablet hardness (~40 N) was comparable between CNF-containing (20%) tablets and those prepared with crystalline cellulose under 10 kN compression force. Disintegration time (~30 s) was similar between CNF-supplemented tablets and those supplemented with low-substituted hydroxypropyl cellulose, crospovidone, or croscarmellose sodium. At higher CNF fractions, tablet hardness increased, while friability decreased. Adding ≥30% CNF prolonged the tablet disintegration time. To set the optimized manufacturing condition for ensuring the desired tablet physical properties, we created contour plots for evaluating the effects of CNF concentration and compression force on hardness and disintegration time. A CNF concentration of 10-20% and a compression force of 12-13 kN would allow for the preparation of tablets with a hardness ≥30 N and a disintegration time ≤60 s. Altogether, addition of CNF to the OD tablet formulation for direct powder compression enhanced hardness and disintegration.
© 2021. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  cellulose nanofiber; direct powder compression; disintegration; hardness; orally disintegrating tablet

Mesh:

Substances:

Year:  2021        PMID: 34950985     DOI: 10.1208/s12249-021-02194-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  19 in total

Review 1.  Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.

Authors:  Yourong Fu; Shicheng Yang; Seong Hoon Jeong; Susumu Kimura; Kinam Park
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2004       Impact factor: 4.889

Review 2.  Orally disintegrating systems: innovations in formulation and technology.

Authors:  Honey Goel; Parshuram Rai; Vikas Rana; Ashok K Tiwary
Journal:  Recent Pat Drug Deliv Formul       Date:  2008

3.  A new formulation for orally disintegrating tablets using a suspension spray-coating method.

Authors:  Y Okuda; Y Irisawa; K Okimoto; T Osawa; S Yamashita
Journal:  Int J Pharm       Date:  2009-08-15       Impact factor: 5.875

4.  Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements.

Authors:  Johannes J Moes; Marco M Ruijken; Erik Gout; Henderik W Frijlink; Michael I Ugwoke
Journal:  Int J Pharm       Date:  2008-03-10       Impact factor: 5.875

Review 5.  The technologies used for developing orally disintegrating tablets: a review.

Authors:  Bhatu P Badgujar; Atish S Mundada
Journal:  Acta Pharm       Date:  2011-06       Impact factor: 2.230

Review 6.  [Clinical functionality required for orally disintegrating tablets selected as the next generation type].

Authors:  Noriyuki Namiki
Journal:  Yakugaku Zasshi       Date:  2015       Impact factor: 0.302

7.  Factor analysis in optimization of formulation of high content uniformity tablets containing low dose active substance.

Authors:  Ivana Lukášová; Jan Muselík; Aleš Franc; Roman Goněc; Filip Mika; David Vetchý
Journal:  Eur J Pharm Sci       Date:  2017-09-11       Impact factor: 4.384

8.  Real time release testing of tablet content and content uniformity.

Authors:  Daniel J Goodwin; Sander van den Ban; Mike Denham; Ian Barylski
Journal:  Int J Pharm       Date:  2017-12-09       Impact factor: 5.875

9.  Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.

Authors:  Wei-Jhe Sun; Aktham Aburub; Changquan Calvin Sun
Journal:  J Pharm Sci       Date:  2017-03-16       Impact factor: 3.534

10.  Preparation and evaluation of combination tablet containing incompatible active ingredients.

Authors:  Xiaoyan Wang; Fude Cui; Yorinobu Yonezawa; Hisakazu Sunada
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-07       Impact factor: 1.645

View more
  1 in total

Review 1.  Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.

Authors:  Andreea Cornilă; Sonia Iurian; Ioan Tomuță; Alina Porfire
Journal:  Pharmaceutics       Date:  2022-08-03       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.